Cencora, Inc. Files 8-K on Asset Acquisition/Disposition
Ticker: COR · Form: 8-K · Filed: Jan 2, 2025 · CIK: 1140859
| Field | Detail |
|---|---|
| Company | Cencora, INC. (COR) |
| Form Type | 8-K |
| Filed Date | Jan 2, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $4.4 b |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, disposition, corporate-action
TL;DR
Cencora just filed an 8-K for asset acquisition/disposition - big moves happening!
AI Summary
On January 2, 2025, Cencora, Inc. (formerly AmerisourceBergen Corp) filed an 8-K report detailing the completion of an acquisition or disposition of assets. The filing also included Regulation FD disclosures and financial statements/exhibits. The company is incorporated in Delaware and its principal business address is 1 West First Avenue, Conshohocken, PA.
Why It Matters
This filing indicates a significant corporate action, such as an acquisition or sale of assets, which could impact Cencora's business operations, financial performance, and strategic direction.
Risk Assessment
Risk Level: medium — Acquisitions or dispositions of assets can introduce significant financial and operational risks, depending on the scale and nature of the transaction.
Key Players & Entities
- Cencora, Inc. (company) — Registrant
- AmerisourceBergen Corp (company) — Former company name
- January 2, 2025 (date) — Date of earliest event reported
- 1 West First Avenue, Conshohocken, PA 19428-1800 (address) — Principal business address
FAQ
What specific assets were acquired or disposed of by Cencora, Inc.?
The filing indicates the completion of an acquisition or disposition of assets, but the specific details of the assets involved are not provided in this summary.
What was the financial impact of this transaction on Cencora, Inc.?
The filing mentions financial statements and exhibits, but the specific financial impact of the asset transaction is not detailed in this summary.
When did the acquisition or disposition of assets officially close?
The report is dated January 2, 2025, and indicates the completion of the transaction as of that date.
Are there any regulatory implications mentioned regarding this asset transaction?
The filing includes 'Regulation FD Disclosure,' suggesting adherence to fair disclosure regulations, but specific regulatory implications of the asset transaction are not detailed here.
What is the primary business of Cencora, Inc.?
Cencora, Inc. is in the 'WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES' industry, as indicated by its Standard Industrial Classification code.
Filing Stats: 613 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2025-01-02 17:00:24
Key Financial Figures
- $4.4 b — he Company's cash outlay at closing was $4.4 billion, which amount is subject to a cus
Filing Documents
- tm2432308d1_8k.htm (8-K) — 28KB
- tm2432308d1_ex99-1.htm (EX-99.1) — 15KB
- tm2432308d1_ex99-1img001.jpg (GRAPHIC) — 4KB
- 0001104659-25-000366.txt ( ) — 222KB
- cor-20250102.xsd (EX-101.SCH) — 3KB
- cor-20250102_lab.xml (EX-101.LAB) — 33KB
- cor-20250102_pre.xml (EX-101.PRE) — 22KB
- tm2432308d1_8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Cencora, Inc. Date: January 2, 2025 By: /s/ James F. Cleary Name: James F. Cleary Title: Executive Vice President and Chief Financial Officer